Hypertensive crisis

E. B. Rubenstein, C. Escalante

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations

Abstract

Hypertensive crisis is an acute emergency requiring aggressive management. Its incidence has decreased in recent years but still is prevalent in the medical community. From review of past and present treatment regimens, the following recommendations can be considered. In the treatment of malignant hypertension with associated CHF, sodium nitroprusside is still an excellent agent. It has a rapid onset of action and blood pressure can be easily titrated. Nitroglycerin is also another agent that can be used in this situation. In the treatment of malignant hypertension with associated aortic dissection, trimethophan camsylate is the preferred agent. An alternative choice is the combination of nitroprusside and labetalol. In the treatment of malignant hypertension with associated myocardial ischemia, an excellent choice is nitroglycerin. Labetalol also should be considered in this situation. In the treatment of hypertension during pregnancy, hydralazine is still a good choice. Labetalol has also been shown to be efficacious. In the treatment of malignant hypertension with associated cerebral ischemia, the following drugs should be considered: nitroprusside, nitroglycerin, and labetalol. The most important attribute of these agents is that they are nonsedating and rapid in onset. In the treatment of postoperative hypertension the choices best suited are labetalol, enalaprilat, nitroprusside, and nitroglycerin. These agents are rapid in onset and all can be administered intravenously.

Original languageEnglish (US)
Pages (from-to)477-495
Number of pages19
JournalCritical Care Clinics
Volume5
Issue number3
DOIs
StatePublished - 1989

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Fingerprint

Dive into the research topics of 'Hypertensive crisis'. Together they form a unique fingerprint.

Cite this